Back
Cytokinetics Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
42
CYTK
Cytokinetics
Last Price:
51.37
Seasonality Move:
10.01%
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
127.69
Seasonality Move:
11.13%
Sell
42
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $51.51. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $51.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.19
The current trend is relatively stagnant and SRPT is experiencing slight selling pressure.
CYTK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 40.31 | Sell |
Chaikin Money Flow: | -241160 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.28 - 55.12) | Sell |
Bollinger Bands (100): | (52.99 - 56.93) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.05 | Buy |
Relative Strength Index (14 RSI): | 58.34 | Buy |
Chaikin Money Flow: | -9031 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.84 - 128.84) | Buy |
Bollinger Bands (100): | (123 - 147.2) | Sell |
CYTK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.03 | Sell |
20-day SMA: | 53.96 | Sell |
50-day SMA: | 54.65 | Sell |
200-day SMA: | 62.09 | Sell |
8-day EMA: | 52.73 | Sell |
20-day EMA: | 53.56 | Sell |
50-day EMA: | 54.42 | Sell |
200-day EMA: | 55.79 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.53 | Buy |
20-day SMA: | 124.83 | Buy |
50-day SMA: | 128.74 | Buy |
200-day SMA: | 130.35 | Sell |
8-day EMA: | 129.2 | Buy |
20-day EMA: | 127.16 | Buy |
50-day EMA: | 128.69 | Buy |
200-day EMA: | 127.96 | Buy |
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
Cytokinetics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |